ArticleScientific reports2025
Lignin nanoparticle-enhanced PVA foils for UVB/UVC protection.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Advancing polyallophanate powder coating performance and function with colloidal lignin particles.RSC advances · 2026Article
- Design of UV-Resistant Polylactide-Based Coating Systems: Effect of Plasticizers and Fillers on Durability and Degradation Behavior.Materials (Basel, Switzerland) · 2026Article
- Nanomaterial Integration at Liquid-Liquid Interfaces for Green Catalysis.Advanced materials (Deerfield Beach, Fla.) · 2026Review
- Entanglement-Mediated Dispersion of Lignin Nanoparticles in PVA Networks for Transparent and Tough Bio-Composites.Polymers · 2026Article
- Sustainable Waterborne Polylactide Coatings Enabled by Hydrophobic Deep Eutectic Solvents Plasticization.Polymers · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The growing demand for sustainable packaging, stricter regulations on non-biodegradable plastic waste, and increasing consumer awareness of environmental pollution are driving the development of water-soluble packaging materials. This study investigates the potential of lignin nanoparticles (LNPs) derived from spruce kraft lignin (SKL) and eucalyptus kraft lignin (EKL), as functional additives in polyvinyl alcohol (PVA)-based films to achieve an optimal balance between high transparency and effective UV protection. To improve LNP dispersion within the PVA matrix, hydrophobic domains were introduced into lignin via acetylation, as confirmed by ³¹P NMR spectroscopy. The morphology of the nanoparticles was analyzed using transmission electron microscopy (TEM). The resulting PVA-LNP nanocomposite films exhibited excellent transparency and outstanding UV-shielding capabilities. UV-Vis spectroscopy confirmed the UV-blocking performance of the films, revealing that EKL-derived nanoparticles (EKL-C1) enhanced UV absorption more than eightfold compared to neat PVA, while SKL-derived nanoparticles (SKL-C1) achieved a 6.5-fold increase. This superior performance can be attributed to the higher syringyl (S) unit content and abundant methoxy groups in EKL-C1, which can improve UV absorption efficiency. Atomic force microscopy (AFM) further demonstrated smoother surface morphologies for EKL-C1-containing films, indicating improved nanoparticle dispersion and reduced aggregation. Mechanical testing before and after UV exposure confirmed the suitability of the films for packaging applications. These findings highlight the potential of lignin-based nanocomposite films as eco-friendly packaging and coating materials, offering a unique combination of high transparency and robust UV protection while, providing valuable insights into the structure-property relationships of lignin nanoparticles in biodegradable polymer films.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.